Multiple sclerosis symptoms and spasticity management: new data.

about

Multiple sclerosis symptoms and spasticity management: new data.

Item

http://www.wikidata.org/entity/Q47588014

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Multiple sclerosis symptoms and spasticity management: new data.

@en

Multiple sclerosis symptoms and spasticity management: new data.

@nl

type

Item

label

Multiple sclerosis symptoms and spasticity management: new data.

@en

Multiple sclerosis symptoms and spasticity management: new data.

@nl

prefLabel

Multiple sclerosis symptoms and spasticity management: new data.

@en

Multiple sclerosis symptoms and spasticity management: new data.

@nl

P1476

Multiple sclerosis symptoms and spasticity management: new data.

@en

P2093

Guillermo Izquierdo

http://www.w3.org/2001/XMLSchema#string

P2860

Cannabis use in patients with multiple sclerosis

Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis

Sativex(®) (tetrahydrocannabinol + cannabidiol), an endocannabinoid system modulator: basic features and main clinical data.

Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients.

A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol.

Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis.

A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis.

A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK.

Cannabis use and risk of lung cancer: a case-control study.

Combined cannabinoid therapy via an oromucosal spray.

P304

7-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/NMT-2017-0034

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29143581

http://www.w3.org/2001/XMLSchema#string